1. Home
  2. FNWB vs IMRX Comparison

FNWB vs IMRX Comparison

Compare FNWB & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • IMRX
  • Stock Information
  • Founded
  • FNWB 1923
  • IMRX 2008
  • Country
  • FNWB United States
  • IMRX United States
  • Employees
  • FNWB N/A
  • IMRX N/A
  • Industry
  • FNWB Banks
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • IMRX Health Care
  • Exchange
  • FNWB Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • FNWB 79.5M
  • IMRX 68.4M
  • IPO Year
  • FNWB 2015
  • IMRX 2021
  • Fundamental
  • Price
  • FNWB $8.13
  • IMRX $3.44
  • Analyst Decision
  • FNWB Hold
  • IMRX Strong Buy
  • Analyst Count
  • FNWB 1
  • IMRX 4
  • Target Price
  • FNWB $12.00
  • IMRX $13.25
  • AVG Volume (30 Days)
  • FNWB 50.2K
  • IMRX 2.9M
  • Earning Date
  • FNWB 07-24-2025
  • IMRX 08-05-2025
  • Dividend Yield
  • FNWB 3.44%
  • IMRX N/A
  • EPS Growth
  • FNWB N/A
  • IMRX N/A
  • EPS
  • FNWB N/A
  • IMRX N/A
  • Revenue
  • FNWB $45,593,000.00
  • IMRX N/A
  • Revenue This Year
  • FNWB $38.07
  • IMRX N/A
  • Revenue Next Year
  • FNWB $13.43
  • IMRX N/A
  • P/E Ratio
  • FNWB N/A
  • IMRX N/A
  • Revenue Growth
  • FNWB N/A
  • IMRX N/A
  • 52 Week Low
  • FNWB $6.05
  • IMRX $1.00
  • 52 Week High
  • FNWB $12.10
  • IMRX $3.87
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 48.31
  • IMRX 67.76
  • Support Level
  • FNWB $6.05
  • IMRX $2.29
  • Resistance Level
  • FNWB $8.89
  • IMRX $3.87
  • Average True Range (ATR)
  • FNWB 0.53
  • IMRX 0.47
  • MACD
  • FNWB 0.10
  • IMRX 0.08
  • Stochastic Oscillator
  • FNWB 73.24
  • IMRX 80.89

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: